Tempest Therapeutics (TPST) EBITDA Margin Growth (1y) (2016 - 2018)
Powered by 
Analysis
Tempest Therapeutics (TPST) EBITDA Margin Growth (1y) (2016 - 2018) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Krystal Biotech | 10.26 Bn | 9.41 Bn | 112.79 Mn | 798.00 |
| 2 | CRISPR Therapeutics AG | 5.04 Bn | 5.04 Bn | - | 2.46 Mn |
| 3 | Iovance Biotherapeutics | 3.66 Bn | 3.36 Bn | 55.72 Mn | 13,751.00 |
| 4 | Legend Biotech | 3.55 Bn | 2.58 Bn | 251.50 Mn | 2,348.00 |
| 5 | uniQure | 2.95 Bn | 2.95 Bn | 5.49 Mn | -6,012.00 |
| 6 | Beam Therapeutics | 2.54 Bn | 2.54 Bn | - | -2.44 Mn |
| 7 | Precigen | 2.38 Bn | 2.38 Bn | 52.17 Mn | 375,193.00 |
| 8 | Sarepta Therapeutics | 2.16 Bn | 1.37 Bn | 251.87 Mn | -1,560.00 |
| 9 | Vericel | 1.93 Bn | 1.77 Bn | 56.40 Mn | 377.00 |
| 10 | Tempest Therapeutics | 3.35 Mn | 2.55 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2018 | 260,370.00 |
| Jun 30, 2018 | 1.52 Mn |
| Mar 31, 2018 | 1.66 Mn |
| Dec 31, 2017 | -2.81 Mn |
| Sep 30, 2017 | -717,003.00 |
| Jun 30, 2017 | -1.17 Mn |
| Mar 31, 2017 | -846,972.00 |
| Dec 31, 2016 | -559,423.00 |
| Sep 30, 2016 | 1.41 Mn |
| Jun 30, 2016 | 4.76 Mn |
| Mar 31, 2016 | 9.74 Mn |